# US 2004/0079652 A1 · Methods of determining glucose concentration in whole blood samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0079652 A1
- Document ID: US20040079652A1
- Status: Published application
- Kind: A1
- Application number: 10/645,785
- Filed: 2003-08-22
- Published: 2004-04-29
- Earliest claimed: 2002-08-27
- Assignees: Bayer HealthCare LLC
- Inventors: Mark S. Vreeke; Marvin A. Genshaw; Bryan S. Melle
- Web page: https://patentgrep.com/patent/US20040079652A1

## CPC

- G01N 27/3274: {Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration (coding of calibration information G01N33/48771)}
- G01N 33/66: involving blood sugars, e.g. galactose
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The glucose concentration in a whole blood sample may be determined by providing an electrochemical sensor adapted to measure glucose and hematocrit concentrations. The hematocrit concentration of the whole blood sample is measured using the electrochemical sensor via electrochemical impedance spectroscopy. The initial glucose concentration of the whole blood sample is measured using the electrochemical sensor. The unbiased glucose concentration in the whole blood sample is calculated using the initial glucose concentration measurement and the hematocrit concentration.

## Claims

### Claim 1

A method of determining glucose concentration in a whole blood sample comprising:
providing an electrochemical sensor adapted to measure glucose and hematocrit concentrations;
measuring the hematocrit concentration of the whole blood sample using the electrochemical sensor via electrochemical impedance spectroscopy;
measuring the initial glucose concentration of the whole blood sample using the electrochemical sensor; and
calculating the unbiased glucose concentration in the whole blood sample using the initial glucose concentration measurement and the hematocrit concentration.

### Claim 2 (depends on 1)

The method of claim 1, wherein the glucose concentration of the whole blood sample is determined using an amperometric monitoring system.

### Claim 3 (depends on 1)

The method of claim 1, wherein the electrochemical sensor includes an insulating base plate, an electrode system on the base plate and a cover adapted to mate with the base plate to form a space in which the electrode layer is available to contact the whole blood sample.

### Claim 4 (depends on 3)

The method of claim 3 further including a reaction layer comprising an enzyme that reacts with the glucose in the whole blood sample.

### Claim 5 (depends on 4)

The method of claim 4, wherein the enzyme in the reaction layer is combined with a hydrophilic polymer.

### Claim 6 (depends on 1)

The method of claim 1, wherein the method of determining glucose concentration in a whole blood sample occurs in disposable self-testing systems.

### Claim 7 (depends on 1)

The method of claim 1, wherein the method of determining glucose concentration in a whole blood sample occurs in a clinical analyzer.

### Claim 8 (depends on 1)

The method of claim 1, wherein the measuring of the hematocrit concentration in the whole blood sample is performed before measuring the initial glucose concentration.

### Claim 9 (depends on 1)

The method of claim 1, wherein the measuring of the hematocrit concentration of the whole blood sample is performed using a single frequency measurement.

### Claim 10 (depends on 1)

The method of claim 1, wherein the measuring of the hematocrit concentration of the whole blood sample is performed using a plurality of frequency measurements.

### Claim 11 (depends on 1)

The method of claim 1, wherein the measuring of the hematocrit concentration is performed using a phase shift of an impedance measurement.

### Claim 12 (depends on 11)

The method of claim 11, wherein the measuring of the hematocrit concentration is performed with at least one frequency between about 800 and about 900 Hz.

### Claim 13 (depends on 1)

The method of claim 1, wherein the measuring of the hematocrit concentration is performed using magnitude components of an impedance measurement.

### Claim 14 (depends on 13)

The method of claim 13, wherein the measuring of the hematocrit is performed with at least one frequency between about 300 and about 10,000 Hz.

### Claim 15 (depends on 1)

The method of claim 1 further including applying AC waveforms from about 1 to about 10,000 Hz to the electrochemical sensor.

### Claim 16 (depends on 1)

The method of claim 1 further including applying AC waveforms from about 1 to about 100 mV to the electrochemical sensor.

### Claim 17 (depends on 1)

The method of claim 1 further applying AC waveforms that are subsequently deconvoluted using a Fourier transform.

### Claim 18

A method of determining glucose concentration in a whole blood sample comprising:
providing an electrochemical sensor adapted to measure glucose and hematocrit concentrations;
measuring the hematocrit concentration of the whole blood sample using the electrochemical sensor via electrochemical impedance spectroscopy using an amperometric monitoring system;
measuring the initial glucose concentration of the whole blood sample using the electrochemical sensor; and
calculating the unbiased glucose concentration in the whole blood sample using the initial glucose concentration measurement and the hematocrit concentration.

### Claim 19 (depends on 18)

The method of claim 18, wherein the method of determining glucose concentration in a whole blood sample occurs in disposable self-testing systems.

### Claim 20 (depends on 19)

The method of claim 19, wherein the measuring of the hematocrit concentration of the whole blood sample is performed using a single frequency measurement.

### Claim 21 (depends on 19)

The method of claim 19, wherein the measuring of the hematocrit concentration of the whole blood sample is performed using a plurality of frequency measurements.

### Claim 22 (depends on 19)

The method of claim 19, wherein the measuring of the hematocrit concentration is performed using a phase shift of an impedance measurement.

### Claim 23 (depends on 22)

The method of claim 22, wherein the measuring of the hematocrit concentration is performed with at least one frequency between about 800 and about 900 Hz.

### Claim 24 (depends on 19)

The method of claim 19, wherein the measuring of the hematocrit concentration is performed using magnitude components of an impedance measurement.

### Claim 25 (depends on 24)

The method of claim 24, wherein the measuring of the hematocrit is performed with at least one frequency between about 300 and about 10,000 Hz.

### Claim 26 (depends on 19)

The method of claim 19 further including applying AC waveforms from about 1 to about 10,000 Hz to the electrochemical sensor.

### Claim 27 (depends on 19)

The method of claim 19 further including applying AC waveforms from about 1 to about 100 mV to the electrochemical sensor.

### Claim 28 (depends on 19)

The method of claim 19 further applying AC waveforms that are subsequently deconvoluted using a Fourier transform.
